REVIEW PAPER
Special aspects in the treatment of systemic lupus erythematosus
Online publication date: 2013-06-26
Reumatologia 2013;51(3):210-214
KEYWORDS
systemic lupus erythematosuspregnancysecondary antiphospholipid syndromepulmonary arterial hypertension
ABSTRACT
We present special aspects in the treatment of systemic lupus erythematosus, including pregnancy and clinically significant co-morbidities such as secondary antiphospholipid syndrome and pulmonary arterial hypertension.
REFERENCES (23)
1.
Kur-Zalewska J, Tłustochowicz W. Przygotowanie chorej na toczeń rumieniowaty układowy do ciąży. Medycyna po Dyplomie 2013; 22: 90-98.
2.
Bertsias G, Ioannidis JPA, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2008; 67: 195-205.
3.
Khamashta MA, Pierangeli S, Harris EN. Antiphospholipid syndrome: overview of pathogenesis, diagnosis, and management. In: Rheumatology. Fifth edition. Mosby Elsevier, Philadelphia 2011.
4.
Khamashta MA. Treatment of antiphospholipid syndrome. In: Systemic Lupus Erythematosus. Mosby Elsevier, 2007.
5.
Niżankowski R. Zakrzepica żył głębokich. W: Choroby wewnętrzne. Wydanie 1. Medycyna Praktyczna, Kraków 2005.
6.
Petri M. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 1996; 5: S16-S22.
7.
Costedoat-Chalumeau N, Amoura Z, Hulot JS, et al. Hydroxychloroquine in systemic lupus erythematosus. Lancet 2007; 369: 1257-1258.
8.
Erkan D, Yazici Y, Peterson MG, et al. A cross-sectional study of clinical thrombotic risk factors and preventive treatment in antiphospholipid syndrome. Rheumatology (Oxford) 2002; 41: 924-929.
9.
Lim W, Crowther MA, Elkelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006; 295: 1050-1057.
10.
Les I, Ruiz-Irastorza G, Khamashta MA. Intensity and duration of anticoagulation therapy in antiphospholipid syndrome. Semin Thromb Hemost 2012; 38: 339-347.
11.
Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 2011; 20: 206-218.
12.
Kähler CM, Colleselli D. Pulmonary arterial hypertension (PAH) in connective tissue diseases. Rheumatology 2006; 45: 11-13.
13.
Distler O, Pignone A. Pulmonary arterial hypertension and rheumatic diseases- from diagnosis to treatment. Rheumatology 2006; 45: 22-25.
14.
Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i leczenia nadciśnienia płucnego, Europejskie Towarzystwo Oddechowe (ERS), przy wsparciu Międzynarodowego Towarzystwa Przeszczepiania Serca i Płuc (ISHLT). Wytyczne dotyczące rozpoznawania i leczenia nadciśnienia płucnego. Kardiologia Polska 2009; 67: 11 (supl. 7).
15.
Lockshin MD. Systemic lupus erythematosus in the pregnant patient and neonatal lupus. In: Rheumatology. Fifth edition. Mosby Elsevier, Philadelphia 2011.
16.
Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association – European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012; 71: 1771-1782.
17.
Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 2012; 64: 797-808.
18.
Ramsey-Goldman R, Mientus JM, Kutzer JE, et al. Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 1993; 20: 1152-1157.
19.
Clowse MEB, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus 2005; 14: 593-597.
20.
Petri M. Pregnancy in systemic lupus erythematosus and neonatal lupus. In: Rheumatology. Fourth edition. Mosby Elsevier, Philadelphia 2008.
21.
Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 2006; 15: 148-155.
22.
Kur-Zalewska J, Choroś D, Bujakowska O i wsp. Zespół HELLP u chorej na toczeń rumieniowaty układowy i wtórny zespół antyfosfolipidowy. Reumatologia 2011; 49: 456-458.
23.
Undas A. Długotrwałe leczenie przeciwzakrzepowe a planowe i doraźne zabiegi. Med Prakt Chir 2011; 3: 65-69.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
